Back to search

Article

Circular RNA-Encoded MET Variant Is a Targetable Factor in Glioblastoma

2022-06-28

Abstract excerpt

<title>Abstract</title> <p>Activated by its single ligand, hepatocyte growth factor (HGF), the receptor tyrosine kinase MET is pivotal in promoting glioblastoma stem cell (GSC) self-renewal, invasiveness and tumorigenicity. Nevertheless, HGF/MET-targeted therapy has shown limited clinical benefits in glioblastoma patients, suggesting hidden mechanisms of MET signalling in glioblastoma. Here, we show that circular...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8aca7140-eba9-5575-85ed-38bcc8b09713
DOI
10.21203/rs.3.rs-1730428/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Circular RNA-Encoded MET Variant Is a Targetable Factor in GlioblastomaDOI 10.21203/rs.3.rs-1730428/v1
Select a neighboring publication to make it the new centre.